|
2024-09-16 |
2024-09-13 |
V
Vente
|
Sermon Charles
General Counsel
Dirigeant
|
20 946
-8.7%
4,22
88 413 USD
|
20 946
-8.7%
|
4,22
|
88 413 USD
|
|
|
2024-09-16 |
2024-09-13 |
V
Vente
|
Fox Christine Ann
Chief Financial Officer
Dirigeant
|
19 158
-17.7%
4,22
80 866 USD
|
19 158
-17.7%
|
4,22
|
80 866 USD
|
|
|
2024-09-16 |
2024-09-13 |
V
Vente
|
Lewicki John A.
Chief Scientific Officer
Dirigeant
|
10 937
-12.2%
4,22
46 165 USD
|
10 937
-12.2%
|
4,22
|
46 165 USD
|
|
|
2024-09-16 |
2024-09-13 |
V
Vente
|
Scots-Knight Denise
Chief Executive Officer
Administrateur exécutif
|
60 046
-6.9%
4,22
253 454 USD
|
60 046
-6.9%
|
4,22
|
253 454 USD
|
|
|
2024-09-16 |
2024-09-13 |
V
Vente
|
Hughes-Wilson Alexandra
See Remarks
Dirigeant
|
84 008
-62.5%
4,22
354 598 USD
|
84 008
-62.5%
|
4,22
|
354 598 USD
|
|
|
2024-09-16 |
2024-09-13 |
V
Vente
|
Hughes-Wilson Alexandra
See Remarks
Dirigeant
|
16 304
-10.8%
4,22
68 819 USD
|
16 304
-10.8%
|
4,22
|
68 819 USD
|
|
|
2024-09-16 |
2024-09-12 |
V
Vente
|
Sermon Charles
General Counsel
Dirigeant
|
9 980
-4.0%
4,47
44 638 USD
|
9 980
-4.0%
|
4,47
|
44 638 USD
|
|
|
2024-09-16 |
2024-09-12 |
V
Vente
|
Fox Christine Ann
Chief Financial Officer
Dirigeant
|
9 128
-7.8%
4,47
40 827 USD
|
9 128
-7.8%
|
4,47
|
40 827 USD
|
|
|
2024-09-16 |
2024-09-12 |
V
Vente
|
Lewicki John A.
Chief Scientific Officer
Dirigeant
|
5 212
-5.5%
4,47
23 312 USD
|
5 212
-5.5%
|
4,47
|
23 312 USD
|
|
|
2024-09-16 |
2024-09-12 |
V
Vente
|
Scots-Knight Denise
Chief Executive Officer
Administrateur exécutif
|
28 611
-3.2%
4,47
127 968 USD
|
28 611
-3.2%
|
4,47
|
127 968 USD
|
|
|
2024-09-16 |
2024-09-12 |
V
Vente
|
Hughes-Wilson Alexandra
See Remarks
Dirigeant
|
40 029
-21.0%
4,47
179 038 USD
|
40 029
-21.0%
|
4,47
|
179 038 USD
|
|
|
2024-09-16 |
2024-09-12 |
V
Vente
|
Hughes-Wilson Alexandra
See Remarks
Dirigeant
|
7 769
-3.9%
4,47
34 748 USD
|
7 769
-3.9%
|
4,47
|
34 748 USD
|
|
|
2024-08-23 |
2024-08-22 |
V
Vente
|
PAKIANATHAN DEEPIKA
Administrateur non-exécutif
|
105 244
-100.0%
4,43
466 210 USD
|
105 244
-100.0%
|
4,43
|
466 210 USD
|
|
|
2024-06-27 |
2024-06-26 |
V
Vente
|
Sermon Charles
General Counsel
Dirigeant
|
32 187
-14.9%
3,39
109 217 USD
|
32 187
-14.9%
|
3,39
|
109 217 USD
|
|
|
2024-06-27 |
2024-06-26 |
V
Vente
|
Lewicki John A.
Chief Scientific Officer
Dirigeant
|
16 808
-25.6%
3,39
57 033 USD
|
16 808
-25.6%
|
3,39
|
57 033 USD
|
|
|
2024-06-27 |
2024-06-26 |
V
Vente
|
Hughes-Wilson Alexandra
See Remarks
Dirigeant
|
22 968
-39.9%
3,39
77 935 USD
|
22 968
-39.9%
|
3,39
|
77 935 USD
|
|
|
2024-06-27 |
2024-06-26 |
V
Vente
|
Fox Christine Ann
Chief Financial Officer
Dirigeant
|
29 439
-33.8%
3,39
99 892 USD
|
29 439
-33.8%
|
3,39
|
99 892 USD
|
|
|
2024-06-27 |
2024-06-26 |
V
Vente
|
Scots-Knight Denise
Chief Executive Officer
Administrateur exécutif
|
92 273
-11.5%
3,39
313 101 USD
|
92 273
-11.5%
|
3,39
|
313 101 USD
|
|
|
2024-06-27 |
2024-06-25 |
V
Vente
|
Sermon Charles
General Counsel
Dirigeant
|
14 202
-6.2%
3,69
52 461 USD
|
14 202
-6.2%
|
3,69
|
52 461 USD
|
|
|
2024-06-27 |
2024-06-25 |
V
Vente
|
Lewicki John A.
Chief Scientific Officer
Dirigeant
|
7 416
-10.2%
3,69
27 394 USD
|
7 416
-10.2%
|
3,69
|
27 394 USD
|
|
|
2024-06-27 |
2024-06-25 |
V
Vente
|
Hughes-Wilson Alexandra
See Remarks
Dirigeant
|
10 134
-15.0%
3,69
37 434 USD
|
10 134
-15.0%
|
3,69
|
37 434 USD
|
|
|
2024-06-27 |
2024-06-25 |
V
Vente
|
Fox Christine Ann
Chief Financial Officer
Dirigeant
|
12 990
-13.0%
3,69
47 984 USD
|
12 990
-13.0%
|
3,69
|
47 984 USD
|
|
|
2024-06-27 |
2024-06-25 |
V
Vente
|
Scots-Knight Denise
Chief Executive Officer
Administrateur exécutif
|
40 712
-4.8%
3,69
150 386 USD
|
40 712
-4.8%
|
3,69
|
150 386 USD
|
|
|
2024-05-23 |
2024-05-22 |
V
Vente
|
Hughes-Wilson Alexandra
See Remarks
Dirigeant
|
50 082
-60.6%
2,94
147 241 USD
|
50 082
-60.6%
|
2,94
|
147 241 USD
|
|
|
2024-05-23 |
2024-05-22 |
V
Vente
|
Hughes-Wilson Alexandra
See Remarks
Dirigeant
|
50 350
-46.2%
2,99
150 547 USD
|
50 350
-46.2%
|
2,99
|
150 547 USD
|
|
